Teodora Vasileva Marinova-Bulgaranova

Mrs. Teodora Vasileva Marinova-Bulgaranova

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Teodora Vasileva Marinova-BulgaranovaTeodora Vasileva Marinova-Bulgaranova
Teodora Vasileva Marinova-Bulgaranova
HHHristina Yotova Hitkova
Hristina Yotova Hitkova
NBNikolay Kirilov Balgaranov
Nikolay Kirilov Balgaranov
Acinetobacter baumannii is one of the most challenging nosocomial pathogens associated with a variety of hospital infections, such as ventilator-associated pneumonia, wound and urinary tract infections, meningitis, and sepsis, primarily in patients treated in critical care settings. Its classification as a high-priority pathogen is due to the emergence of multidrug-resistant strains in healthcare environments and its tendency to spread clonally. A. baumannii belongs to the Acinetobacter calcoaceticus–Acinetobacter baumannii (Acb) complex, a group of genotypically and phenotypically similar species. Differentiating between the species is important because of their distinct clinical significance. However, conventional phenotypic methods, both manual and automated, often fail to provide accurate species-level identification. This review aims to summarize current phenotypic and genotypic methods for the identification of species within the Acb complex, evaluating their strengths and limitations to offer guidance for their appropriate application in diagnostic settings and epidemiological investigations.

26 July 2023 in Gut Pathogens
Verified
Journal Article
Open access
PDF file
PHPreslava Hristova
Preslava Hristova
Teodora Vasileva Marinova-BulgaranovaTeodora Vasileva Marinova-Bulgaranova
Teodora Vasileva Marinova-Bulgaranova
TSTanya V. Strateva
Tanya V. Strateva
STStefan V. Trifonov
Stefan V. Trifonov
HHHristina Y. Hitkova
Hristina Y. Hitkova
Vancomycin-resistant enterococci (VRЕ) are recognized as important hospital pathogens which have become common in patients admitted to the intensive care units (ICUs). The purpose of this study was to evaluate the incidence of and the risk factors for colonization with VRE among ICU patients. A total of 91 patients who had duration of hospitalization more than 48 h and without infection caused by VRE or/and other microorganisms in the ICU at University Hospital, Pleven were screened for colonization with VRE. The following data were collected: demographic characteristics, clinical information and antimicrobials use. The statistical analysis was performed using SPSS version 27.0. Colonization with VRE was established in 22 patients and one was carrying two enterococcal species. A total of 23 VRE were isolated. The univariate analysis showed that the postoperative critical cares (p < 0.001), cardiovascular diseases (p = 0.009) and the presence of an endotracheal tube (p = 0.003) were risk factors for colonization with VRE. Also, the postoperative critical cares (p = 0.021) and cardiovascular diseases (p = 0.018) were confirmed as independent risk factor for VRE acquisition by multivariate analysis. The prevalence of VRE colonization among the ICU patients was relatively high (24.2%). Risk factors for acquisition of intestinal VRE were the postoperative cares, cardiovascular diseases and the presence of an endotracheal tube.

21 November 2020 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
HHHristina Yotova Hitkova
Hristina Yotova Hitkova
DGDiana Simeonova Georgieva
Diana Simeonova Georgieva
PHPreslava Hristova
Preslava Hristova
Teodora Vasileva Marinova-BulgaranovaTeodora Vasileva Marinova-Bulgaranova
Teodora Vasileva Marinova-Bulgaranova
BBBiser Kirilov Borisov
Biser Kirilov Borisov
VPVladimir Georgiev Popov
Vladimir Georgiev Popov
Background: Emerging non-albicans Candida (NAC) species are a major threat because of their intrinsic or acquired resistance to routinely applied antifungal agents. Objectives: The purpose of our study was to reveal in vitro activity of nine antifungal agents against NAC isolates. Methods: A total of 67 NAC (27 Candida glabrata, 10 C. tropicalis, 6 C. krusei, 6 C. parapsilosis, 4 C. lusitaniae, 4 C. lipolytica, etc.) were identified and tested. The antifungal susceptibility was estimated on the basis of minimum inhibitory concentrations (MIC). Results: Overall, 13 species were determined, of which C. glabrata was the most common (40.3%), followed by C. tropicalis (14.9%), C. krusei, and C. parapsilosis (8.9 % each). Forty-nine NAC isolates (73.13%) demonstrated decreased susceptibility to one or more antifungals, and 18 of them were resistant to all azoles. Out of 27 C. glabrata, 12 (44.4%) were resistant to fluconazole with MICs: 32 - >128 µg/mL and 15 (55.6%) were intermediate with MICs: 8 - 16 µg/mL Non-albicans Candida revealed a good susceptibility to echinocandins. Amphotericin B resistance was found in 5.97% of the isolates. Of particular interest was the detection of 6 (8.95%) multidrug-resistant NAC, which expressed resistance to azoles and echinocandins and/or amphotericin B. Conclusions: About one-fourth of the studied NAC were resistant to all azoles. These findings as well as the detection of several multidrug-resistant isolates determine the necessity of susceptibility testing of clinically important yeast isolates and control of the antifungal drugs in our hospital.

24 July 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
Teodora Vasileva Marinova-BulgaranovaTeodora Vasileva Marinova-Bulgaranova
Teodora Vasileva Marinova-Bulgaranova
PHPreslava Mihaylova Hristova
Preslava Mihaylova Hristova
PMPolya Marinovska
Polya Marinovska
NBNikolay Balgaranov
Nikolay Balgaranov
VNVladislav Nankov
Vladislav Nankov
HHHristina Hitkova
Hristina Hitkova
Acinetobacter baumannii is a formidable nosocomial pathogen responsible for severe hospital-acquired infections. This study aimed to investigate the relationship between genotypic and phenotypic resistance profiles in 36 non-duplicate invasive A. baumannii isolates collected at a tertiary care hospital in Bulgaria over a six-year period (2019–2024). Identification was performed by MALDI-TOF MS and PCR-based detection of blaOXA-51-like and gyrB. Antimicrobial susceptibility testing to ten agents was performed by gradient diffusion and broth microdilution, and selected resistance genes were detected by conventional PCR. Whole-genome sequencing of 17 representative isolates was conducted to confirm the resistance genotype–phenotype associations and perform MLST. Carbapenem resistance was detected in 34/36 isolates (94.4%), mediated by blaOXA-23-like (29/34) or blaOXA-72 (5/34). The armA gene associated with high-level resistance to all three aminoglycosides was identified exclusively in blaOXA-23-like-positive isolates (18/29). In armA-negative isolates, gentamicin and tobramycin MICs decreased markedly, whereas amikacin MICs remained elevated. In addition, minocycline MICs ≥ 8 mg/L were observed in the presence of armA. Seven distinct genotypic–phenotypic profiles were defined based on these gene–MIC associations. Resistome and phylogenetic analyses confirmed these relationships, with MLST assigning the isolates to established clonal lineages ST2 and ST636 (International Clone II). These findings support the use of targeted genes, such as armA, combined with phenotypic testing to guide empirical therapy and strengthen local surveillance of high-risk A. baumannii clones in hospital settings.

26 March 2026 in Children
Verified
Journal Article
Open access
PDF file
NBNikolay Balgaranov
Nikolay Balgaranov
SEStanimira Elkina
Stanimira Elkina
IHIRINA Boyanova HALVADZHIYAN
IRINA Boyanova HALVADZHIYAN
Teodora Vasileva Marinova-BulgaranovaTeodora Vasileva Marinova-Bulgaranova
Teodora Vasileva Marinova-Bulgaranova
Background: Chronic sclerosing osteomyelitis of Garré (CSO) is a rare, non-suppurative form of primary chronic osteomyelitis characterized by reactive periosteal bone formation and cortical thickening. It most commonly involves the mandibular bones, whereas long-bone localization is uncommon. Material and Methods: We report a 4-year-old girl who developed progressive right thigh pain and limping six months after receiving intramuscular ampicillin injections. Subsequent evaluation revealed femoral changes consistent with chronic sclerosing osteomyelitis. Surgical decompression and targeted antimicrobial therapy were performed. Results: Microbiological analysis of intraoperative specimens obtained prior to antibiotic therapy yielded Staphylococcus epidermidis (S. epidermidis) and Staphylococcus capitis (S. capitis). After three years of follow-up, the patient exhibited no functional impairment or growth disturbance of the affected limb. Conclusions: Although coagulase-negative staphylococci (CoNS) are commonly regarded as skin commensals, their repeated isolation from deep surgical specimens, together with clinical findings and response to treatment, raises the possibility of their involvement in the disease process in this case.